PPARG and lung cancer: The role of PPARγ agonists as anticancer agents has been well characterized in treatment of colon, gastric, and lung cancer [3, 11], whereas, PPARγ antagonists have been shown to induce potent antiproliferative effects in many hematopoietic and epithelial cancer cell lines [11, 28].